OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
The Emerging Factors and Treatment Options for NAFLD-Related Hepatocellular Carcinoma
Chunye Zhang, Ming Yang
Cancers (2021) Vol. 13, Iss. 15, pp. 3740-3740
Open Access | Times Cited: 29
Chunye Zhang, Ming Yang
Cancers (2021) Vol. 13, Iss. 15, pp. 3740-3740
Open Access | Times Cited: 29
Showing 1-25 of 29 citing articles:
The Related Metabolic Diseases and Treatments of Obesity
Ming Yang, Shuai Liu, Chunye Zhang
Healthcare (2022) Vol. 10, Iss. 9, pp. 1616-1616
Open Access | Times Cited: 72
Ming Yang, Shuai Liu, Chunye Zhang
Healthcare (2022) Vol. 10, Iss. 9, pp. 1616-1616
Open Access | Times Cited: 72
Hepatocellular and extrahepatic cancer risk in people with non-alcoholic fatty liver disease
James A. Thomas, Bradley J. Kendall, Hashem B. El‐Serag, et al.
The Lancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 2, pp. 159-169
Closed Access | Times Cited: 40
James A. Thomas, Bradley J. Kendall, Hashem B. El‐Serag, et al.
The Lancet. Gastroenterology & hepatology (2024) Vol. 9, Iss. 2, pp. 159-169
Closed Access | Times Cited: 40
Pathology and Pathogenesis of Metabolic Dysfunction-Associated Steatotic Liver Disease-Associated Hepatic Tumors
Yoshihisa Takahashi, Erdenetsogt Dungubat, Hiroyuki Kusano, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2761-2761
Open Access | Times Cited: 33
Yoshihisa Takahashi, Erdenetsogt Dungubat, Hiroyuki Kusano, et al.
Biomedicines (2023) Vol. 11, Iss. 10, pp. 2761-2761
Open Access | Times Cited: 33
Cancer Immunotherapy and Delivery System: An Update
Ming Yang, Olamide Tosin Olaoba, Chunye Zhang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1630-1630
Open Access | Times Cited: 28
Ming Yang, Olamide Tosin Olaoba, Chunye Zhang, et al.
Pharmaceutics (2022) Vol. 14, Iss. 8, pp. 1630-1630
Open Access | Times Cited: 28
Hepatocellular Carcinoma and Obesity, Type 2 Diabetes Mellitus, Cardiovascular Disease: Causing Factors, Molecular Links, and Treatment Options
Chunye Zhang, Shuai Liu, Ming Yang
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 35
Chunye Zhang, Shuai Liu, Ming Yang
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 35
Regulatory T cells and their associated factors in hepatocellular carcinoma development and therapy
Chunye Zhang, Shuai Liu, Ming Yang
World Journal of Gastroenterology (2022) Vol. 28, Iss. 27, pp. 3346-3358
Open Access | Times Cited: 27
Chunye Zhang, Shuai Liu, Ming Yang
World Journal of Gastroenterology (2022) Vol. 28, Iss. 27, pp. 3346-3358
Open Access | Times Cited: 27
LINC01468 drives NAFLD-HCC progression through CUL4A-linked degradation of SHIP2
Hongquan Wang, Yan Wang, Shihui Lai, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 21
Hongquan Wang, Yan Wang, Shihui Lai, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 21
Clinical diagnosis and management of pancreatic cancer: Markers, molecular mechanisms, and treatment options
Chunye Zhang, Shuai Liu, Ming Yang
World Journal of Gastroenterology (2022) Vol. 28, Iss. 48, pp. 6827-6845
Open Access | Times Cited: 20
Chunye Zhang, Shuai Liu, Ming Yang
World Journal of Gastroenterology (2022) Vol. 28, Iss. 48, pp. 6827-6845
Open Access | Times Cited: 20
Astaxanthin Prevents Diet-Induced NASH Progression by Shaping Intrahepatic Immunity
Ming Yang, Eric T. Kimchi, Kevin F. Staveley-O’Carroll, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11037-11037
Open Access | Times Cited: 23
Ming Yang, Eric T. Kimchi, Kevin F. Staveley-O’Carroll, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 20, pp. 11037-11037
Open Access | Times Cited: 23
Prognostic efficacy and prognostic factors of TACE plus TKI with ICIs for the treatment of unresectable hepatocellular carcinoma: A retrospective study
Ziqiang Han, Faji Yang, Ye Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
Ziqiang Han, Faji Yang, Ye Zhang, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 16
The Role of Interferon Regulatory Factors in Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis
Chunye Zhang, Shuai Liu, Ming Yang
Gastroenterology Insights (2022) Vol. 13, Iss. 2, pp. 148-161
Open Access | Times Cited: 15
Chunye Zhang, Shuai Liu, Ming Yang
Gastroenterology Insights (2022) Vol. 13, Iss. 2, pp. 148-161
Open Access | Times Cited: 15
Crosstalk between gut microbiota and COVID-19 impacts pancreatic cancer progression
Chunye Zhang, Shuai Liu, Ming Yang
World Journal of Gastrointestinal Oncology (2022) Vol. 14, Iss. 8, pp. 1456-1468
Open Access | Times Cited: 12
Chunye Zhang, Shuai Liu, Ming Yang
World Journal of Gastrointestinal Oncology (2022) Vol. 14, Iss. 8, pp. 1456-1468
Open Access | Times Cited: 12
Utility of Human Relevant Preclinical Animal Models in Navigating NAFLD to MAFLD Paradigm
Damien Chua, Zun Siong Low, Guo Xiang Cheam, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14762-14762
Open Access | Times Cited: 12
Damien Chua, Zun Siong Low, Guo Xiang Cheam, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 23, pp. 14762-14762
Open Access | Times Cited: 12
The Roles of Myeloid-Derived Suppressor Cells in Liver Disease
Chunye Zhang, Yuxiang Sui, Shuai Liu, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 299-299
Open Access | Times Cited: 2
Chunye Zhang, Yuxiang Sui, Shuai Liu, et al.
Biomedicines (2024) Vol. 12, Iss. 2, pp. 299-299
Open Access | Times Cited: 2
Targeting T Cell Subtypes for NAFLD and NAFLD-Related HCC Treatment: An Opinion
Chunye Zhang, Ming Yang
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 15
Chunye Zhang, Ming Yang
Frontiers in Medicine (2021) Vol. 8
Open Access | Times Cited: 15
Functions of three ubiquitin-conjugating enzyme 2 genes in hepatocellular carcinoma diagnosis and prognosis
Chunye Zhang, Ming Yang
World Journal of Hepatology (2022) Vol. 14, Iss. 5, pp. 956-971
Open Access | Times Cited: 9
Chunye Zhang, Ming Yang
World Journal of Hepatology (2022) Vol. 14, Iss. 5, pp. 956-971
Open Access | Times Cited: 9
Diet and Gut Microbiota Interaction-Derived Metabolites and Intrahepatic Immune Response in NAFLD Development and Treatment
Ming Yang, Lea Khoukaz, Xiaoqiang Qi, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1893-1893
Open Access | Times Cited: 12
Ming Yang, Lea Khoukaz, Xiaoqiang Qi, et al.
Biomedicines (2021) Vol. 9, Iss. 12, pp. 1893-1893
Open Access | Times Cited: 12
Glycyrrhizic acid attenuates the malignant biological properties of nonalcoholic fatty liver disease‐related hepatocellular carcinoma
Xueqing Huang, Dengwei You, Tianzhi An, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 10, pp. 4677-4688
Closed Access | Times Cited: 1
Xueqing Huang, Dengwei You, Tianzhi An, et al.
Environmental Toxicology (2024) Vol. 39, Iss. 10, pp. 4677-4688
Closed Access | Times Cited: 1
Immunotherapy for NAFLD and NAFLD-related hepatocellular carcinoma
Seogsong Jeong, Woo-Young Shin, Yun Hwan Oh
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 4
Seogsong Jeong, Woo-Young Shin, Yun Hwan Oh
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 4
Positive association of nap duration with risk of non-alcoholic fatty liver disease in an occupational population in Guangdong Province, China: a cross-sectional study
Chang Hong, Chengkai Wu, Pengcheng Ma, et al.
BMC Gastroenterology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Chang Hong, Chengkai Wu, Pengcheng Ma, et al.
BMC Gastroenterology (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Long Non-Coding RNAs in Non-Alcoholic Fatty Liver Disease; Friends or Foes?
Sina Kalantari Soltanieh, Sahar Khastar, Irwanjot Kaur, et al.
Cell Biochemistry and Biophysics (2024)
Closed Access
Sina Kalantari Soltanieh, Sahar Khastar, Irwanjot Kaur, et al.
Cell Biochemistry and Biophysics (2024)
Closed Access
Immunology and treatments of fatty liver disease
Sainan Tang, Shanshan Wu, Wenzhe Zhang, et al.
Archives of Toxicology (2024) Vol. 99, Iss. 1, pp. 127-152
Closed Access
Sainan Tang, Shanshan Wu, Wenzhe Zhang, et al.
Archives of Toxicology (2024) Vol. 99, Iss. 1, pp. 127-152
Closed Access
Unveiling the Protective Role of Metabolic and Bariatric Surgery Against Primary Liver Cancer in Obesity - A Nationwide French Administrative Data Study.
Andréa Chierici, Fanny FOUR, Julie Bulsei, et al.
Surgery for Obesity and Related Diseases (2024)
Closed Access
Andréa Chierici, Fanny FOUR, Julie Bulsei, et al.
Surgery for Obesity and Related Diseases (2024)
Closed Access
Molecular targets regulating endoplasmic reticulum-mitochondria crosstalk for NAFLD treatment
Chunye Zhang, Ming Yang
Exploration of Medicine (2021)
Open Access | Times Cited: 2
Chunye Zhang, Ming Yang
Exploration of Medicine (2021)
Open Access | Times Cited: 2
The Molecular Mechanisms Underlying Onset and Progression of Liver Cancers
Clara Le Breton, Cédric Coulouarn
Cancers (2023) Vol. 15, Iss. 17, pp. 4383-4383
Open Access
Clara Le Breton, Cédric Coulouarn
Cancers (2023) Vol. 15, Iss. 17, pp. 4383-4383
Open Access
